Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT06947980
Recruiting
Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis
Phase 2 · China · 1 site
Registry update: 17 Aug 2025
NCT06959030
Recruiting
An Observational Study on the Safety and Efficacy of Henagliflozin in Chinese Patients With Type 2 Diabetes
Not applicable · China · 6 sites
Registry update: 8 Jul 2025
NCT06987734
Recruiting
Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients
Phase 2 · China · 1 site
Registry update: 26 Jun 2025
NCT07068191
Recruiting
Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
Not applicable · Russia · 1 site
Registry update: 23 Jul 2025
2024-517325-43-00
Recruiting
IFM2024-06 : A multi-center, open-label, phase 2 randomized study of elranatamab plus lenalidomide versus daratumumab plus lenalidomide as post transplantation maintenance therapy in patients with newly-diagnosed myeloma
Phase 2 · France · 38 sites
Registry update: 10 Jul 2026
NCT06940336
Recruiting
To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy
Phase 4 · China · 1 site
Registry update: 30 Jul 2025
NCT07065240
Recruiting
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Phase 2 · Bulgaria, Czechia, Germany, Hungary, Poland, Romania, Slovakia, United States · 59 sites
Registry update: 10 Nov 2026
NCT06850623
Recruiting
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
Phase 2 · United Kingdom, United States · 10 sites
Registry update: 13 Oct 2026
NCT06755632
Recruiting
Screening of Patients With Hepatic Fibrosis or Cirrhosis B and C
Not applicable · France · 2 sites
Registry update: 23 Jul 2026
NCT06620835
Recruiting
Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
Phase 2 · France · 27 sites
Registry update: 29 Apr 2026
NCT07002476
Recruiting
Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion
Phase 3 · China · 1 site
Registry update: 2 Sept 2026
NCT06926790
Recruiting
Neoadjuvant Nivolumab Plus Ipilimumab in Resectable NSCLC (GALAXY 3)
Phase 2 · China · 1 site
Registry update: 9 Nov 2026
NCT06919614
Recruiting
STI Testing to Enhance PrEP Use in Pregnancy
Phase 3 · Botswana · 1 site
Registry update: 11 Jun 2026
NCT07051005
Recruiting
Feasibility of a Tailored Online Self-compassion Intervention
Not applicable · United Kingdom · 2 sites
Registry update: 20 Mar 2026
NCT06938269
Recruiting
A Study to Evaluate MWN109 Tablets in Healthy Adult Participants
Phase 1 · Australia · 2 sites
Registry update: 20 Nov 2025
NCT06856213
Recruiting
Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.
Phase 2 · Spain · 16 sites
Registry update: 4 Jun 2026
NCT06786234
Recruiting
A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial
Phase 2 · France, United Kingdom · 14 sites
Registry update: 16 Jun 2026
NCT06724237
Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
Phase 3 · Mexico, United States · 165 sites
Registry update: 14 Sept 2026
NCT07924839
Recruiting
PM2.5 Exposure, Obesity, and Cardiovascular Health
Not applicable · United States · 1 site
Registry update: 9 Nov 2026
NCT07581496
Recruiting
T1G3R-1 Trial: Detectability and Prognostic Value of ctDNA in T1 G3 Bladder Cancer
Not applicable · Switzerland · 2 sites
Registry update: 18 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.